Endometrial cancer trials in Israel
10 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
- Where
- Hadera, Haifa, Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv
- Age
- 18 years and over
- People
- 480 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT06340568 · EU 2023-507525-42-00 - Phase 3Taking peopleA Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- Where
- Haifa, Jerusalem, Kfar Saba, Tel Aviv
- Age
- 18 years and over
- People
- 1,123 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06952504 · EU 2024-519331-42-00 - Phase 3Taking peopleStudy to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
- Where
- Ashdod, Haifa, Holon, Jerusalem, Nahariya
- Age
- 18 years and over
- People
- 660 worldwide
- Run by
- Genmab
See details and how to joinNCT07166094 - Phase 3Taking peopleA Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)
- Where
- Haifa, Kfar Saba
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07286331 · EU 2025-523362-25-00 - Phase 3Taking peopleA Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer in Adjuvant Setting
- Where
- Holon
- Age
- 18 years and over
- People
- 710 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT07022483 · EU 2024-519444-33-00 - Phase 1/2Taking peoplePhase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
- Where
- Haifa, Ramat Gan
- Age
- 18 years to 130 years
- People
- 622 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05797168 · EU 2022-502576-23-00 - Phase 1/2Taking peopleStudy of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
- Where
- Haifa, Jerusalem, Tel HaShomer
- Age
- 18 years and over
- People
- 890 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT03564340 · EU 2024-510783-23-00 - Phase 3Taking peoplePuxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Where
- Ashdod, Hadera, Haifa, Holon, Jerusalem, Nahariya, Ramat Gan, Safed, Tel Aviv
- Age
- 18 years and over
- People
- 800 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07044336 · EU 2024-518777-34-00 - No phaseTaking peopleOutcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study
- Where
- Kefar Sava
- People
- 212 worldwide
- Run by
- Mayo Clinic
See details and how to joinNCT06689956 - Phase 2/3Taking peopleStudy of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
- Where
- Haifa, Jerusalem, Tel Aviv
- Age
- 18 years and over
- People
- 268 worldwide
- Run by
- Kartos Therapeutics, Inc.
See details and how to joinNCT05797831